Publisher
Springer Science and Business Media LLC
Subject
Cellular and Molecular Neuroscience,General Medicine
Reference80 articles.
1. Abe K, Itoyama Y, Sobue G, Tsuji S, Aoki M, Doyu M, Edaravone ALS Study Group (2014) Confirmatory double-blind, parallel-group, placebo-controlled study of efficacy and safety of edaravone (MCI-186) in amyotrophic lateral sclerosis patients. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 15(7–8):610–617
2. Active clinical trial studies (2023) Centers for Disease Control and Prevention. Centers for Disease Control and Prevention. Available at: https://www.cdc.gov/als/ALSResearchNotificationClinicalTrialsStudies_Active.html (Accessed: 7 May 2023)
3. Ahmadi M, Agah E, Nafissi S, Jaafari MR, Harirchian MH, Sarraf P, Tafakhori A (2018) Safety and efficacy of nanocurcumin as add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a pilot randomized clinical trial. Neurotherapeutics 15(2):430–438
4. Al-Chalabi A, Hardiman O (2013) The epidemiology of ALS: a conspiracy of genes, environment and time. Nat Rev Neurol 9(11):617–628
5. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Sherlock G (2000) Gene ontology: tool for the unification of biology. Nat Genet 25(1):25–29
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献